FundingWatcher
Home / Startups / Top biotech startups / Biotech startups in Nanjing, China

Biotech startups in Nanjing, China

Updated 16 Nov 2026

Reset
Biotech startups in Nanjing, China
One-time CSV
  • 70 funded companies, 42 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech~nanjing-jiangsu.csv70 rows × 18 columns
CompanyCityLast roundAmountDate
Weikaier Pharmaceutical TechnologyNanjingSeries C$29.6M2026-06-02
IMPACT TherapeuticsNanjingSeries D$34.6M2024-11-15
Zenshine PharmaNanjingSeries C$13.7M2023-10-13
Wimi bioNanjingSeries A$14.1M2024-09-19

4 rows of the CSV in 5 of its 18 columns.

70
Startups
$1.1B
Total raised
11
Funded in the last 12 months
$84.5M
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

4 of 70
Company What they do Sector Last round Amount Date Total raised Investors Employees Founded
Weikaier Pharmaceutical Technology Weikaier Pharmaceutical Technology conducts drug research, transfers generic drug technology, and produces and sells pharmaceuticals. Biotech Series C $29.6M 2026-06-02 $120.4M SDIC Venture Capital, Dyee Capital, Nanjing Innovation Capital Group +1 501 to 1,000 2010
IMPACT Therapeutics IMPACT Therapeutics develops similar drugs to treat cancer. Biotech Series D $34.6M 2024-11-15 BioVenture, Lilly Asia Ventures, Decheng Capital +2 51 to 100 2009
Wimi bio Wimi Bio researches and develops gene editing and biological breeding technologies as a high-tech enterprise. Biotech Series A $14.1M 2024-09-19 HosenCare Brothers 51 to 100 2017
Zenshine Pharma Zenshine Pharma develops small molecule drugs for cancer and autoimmune diseases. Biotech Series C $13.7M 2023-10-13 $28.7M Matrix Partners China, Cybernaut Venture Capital, Kunlun Capital +2 11 to 50 2018

Table 1. Biotech startups in Nanjing, China: the 4 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 70.

Largest rounds

Last 12 months
# Company What they do Sector Last round Amount Date Total raised Investors Employees Founded
1 Weikaier Pharmaceutical Technology Weikaier Pharmaceutical Technology conducts drug research, transfers generic drug technology, and produces and sells pharmaceuticals. Biotech Series C $29.6M 2026-06-02 $120.4M SDIC Venture Capital, Dyee Capital, Nanjing Innovation Capital Group +1 501 to 1,000 2010

Table 2. Biotech startups in Nanjing, China: the 1 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 SDIC Venture Capital Venture capital firm Xicheng, China 1 1% 1 Weikaier Pharmaceutical Technology
2 Nanjing Innovation Capital Group Venture capital firm Nanjing, China 1 1% 1 Weikaier Pharmaceutical Technology
3 Dyee Capital Private equity firm Xiamen, China 1 1% 1 Weikaier Pharmaceutical Technology
4 China Life Private Equity Investment Private equity firm Beijing, China 1 1% 1 Weikaier Pharmaceutical Technology
5 WuXi Healthcare Ventures Venture capital firm Cambridge, United States 1 1%
6 Guangzhou Yuexiu Industrial Investment Fund Corporate venture arm Guangzhou, China 1 1%
7 Lilly Asia Ventures Venture capital firm Shanghai, China 1 1%
8 BioVenture Venture capital firm Suzhou, China 1 1%
9 Decheng Capital Venture capital firm Menlo Park, United States 1 1%
10 Matrix Partners China Venture capital firm Beijing, China 1 1%
11 Summit Capital Family office Seattle, United States 1 1%
12 Hankang Capital Venture capital firm Shanghai, China 1 1%
13 Kunlun Capital Venture capital firm Beijing, China 1 1%
14 Cybernaut Venture Capital Private equity firm Hangzhou, China 1 1%
15 HosenCare Brothers Venture capital firm Beijing, China 1 1%

Table 3. Biotech startups in Nanjing, China: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 59 84% $1.1B
Artificial intelligence 1 1%
Software 1 1%

Table 4. Biotech startups in Nanjing, China by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Seed 15 21% $789K
Series A 26 37% $14.1M
Series B 11 16% $14.0M
Series C 15 21% $29.6M
Series D+ 3 4% $25.0M

Table 5. Biotech startups in Nanjing, China by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
October 2026 3 27%
July 2026 1 9% $29.5M
June 2026 1 9% $29.6M
May 2026 1 9%
January 2026 2 18% $483K
December 2025 1 9% $25.0M
November 2025 2 18%

Table 6. Biotech startups in Nanjing, China: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 8 11% $59.5M
2025 14 20% $99.7M
2024 5 7% $78.9M
2023 14 20% $70.0M
2022 8 11% $107.3M
2021 6 9% $325.2M

Table 7. Biotech startups in Nanjing, China by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 3 4%
2020 to 2022 13 19%
2015 to 2019 34 49%
2010 to 2014 13 19%
Before 2010 7 10%

Table 8. Biotech startups in Nanjing, China by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 4 7%
11 to 50 15 27%
51 to 100 14 25%
101 to 250 7 12%
251 to 500 5 9%
501 to 1,000 7 12%
1,001 to 5,000 4 7%

Table 9. Biotech startups in Nanjing, China by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in Nanjing, China are on the list?
70, in the file dated 16 November 2026. 11 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 70 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups in Nanjing, China: 70 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech startups in Nanjing, China by funding stage

Other sectors in Nanjing

Biotech startups elsewhere

Cite: FundingWatcher, 70 funded biotech companies in Nanjing, China, 16 November 2026. https://fundingwatcher.com/startups/biotech/nanjing-jiangsu/